Andrei-Dan H.
- Country
- France
- Department
- Oncology
Research Overview
- Phase II Randomized Trial of Modified FOLFIRINOX and FOLFOX Regimens in Locally Advanced or Metastatic Small Bowel Adenocarcinoma
- Neoadjuvant Dostarlimab and Short-Course Radiotherapy in Microsatellite Unstable or Mismatch Repair-Deficient Locally Advanced Rectal Cancer
- Evaluation of Neo-Adjuvant Chemotherapy with FOLFOX Regimen in Elderly Patients with Locally Advanced Resectable Colon Carcinoma
Data & Insights
Has run more than one trial at 62 of 208 partner sites.
Specializations
Oncology Focus
The investigator specializes in the treatment of head and neck squamous cell carcinoma, with particular emphasis on advanced disease states including recurrent and metastatic conditions.
- Head and neck cancer therapeutics
- Advanced tumor management
- Metastatic disease treatment
Their research encompasses innovative treatment approaches for complex head and neck malignancies.
Immunotherapy Research
The investigator's work centers on immunotherapeutic approaches in oncology, particularly exploring the therapeutic potential of PD-L1 targeted treatments in head and neck cancers.
- Immune checkpoint inhibition
- PD-L1 positive cancer treatment
- Combination therapy strategies
Their expertise extends to evaluating novel immunotherapy combinations for enhanced treatment outcomes.
Therapeutic Innovation
The investigator focuses on developing novel therapeutic combinations for treating advanced head and neck cancers, incorporating both established and experimental treatment modalities.
- Novel drug combinations
- Treatment resistance strategies
- Advanced therapeutic protocols
Their work includes evaluation of targeted therapies in combination with immunotherapy approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.